Arkolith/Insider Trading/ARMP/Form 4

Innoviva, Inc.

Director, 10% OwnerArmata Pharmaceuticals, Inc. (ARMP) · full profile →Form 4 · filed Apr 1, 2022
Net Buying
Open-Market Buys
$26.9M
Open-Market Sells
$0
Net Open-Market Flow
$26.9M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Buy(P)5.4M$5.00$26.9M16.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2022Buy(P)0$5.00$02.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-007861) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML